文献速递冠心病

美国STEMI患者诊疗流程与结局的机构间变异

Institutional Variability in Processes of Care and Outcomes Among Patients With STEMI in the US.
PubMed 文献 · JAMA Cardiol · 2025-01-01

直接就诊者59.5%达标≤90分钟,转运者50.3%达标≤120分钟,未达标与院内死亡风险升高相关,低绩效医院死亡风险亦增高。

要点

  • 直接就诊者59.5%达标≤90分钟,转运者50.3%达标≤120分钟。
  • 未达标者院内死亡风险升高:直接就诊aOR 2.21,转运aOR 2.44。
  • 低绩效医院较高绩效医院死亡风险增高(aOR 1.16)。

核心结论

  • STEMI患者FMC-to-device时间达标存在显著医院间变异,未达标和低绩效医院均与更差结局相关。

研究设计与样本

  • 回顾性横断面研究,来自美国心脏协会GWTG-CAD注册研究2020–2022年503家美国医院。

主要发现

  • 直接就诊达标率中位数60.8%(IQR 51.2%-68.8%),转运达标率中位数50.0%(IQR 32.5%-66.9%)。
  • 未达标与院内死亡风险升高相关:直接就诊aOR 2.21(95%CI 2.02-2.42),转运aOR 2.44(95%CI 1.90-3.12)。
  • 低绩效医院较高绩效医院直接就诊者死亡风险增高(aOR 1.16,95%CI 1.00-1.34)。
  • 农村与城市医院达标 odds 无显著差异:直接就诊aOR 1.20(95%CI 0.96-1.50),转运aOR 0.86(95%CI 0.50-1.47)。

关键数值与推荐

  • 直接就诊于PCI能力医院的目标FMC-to-device时间≤90分钟。
  • 转运患者的目标FMC-to-device时间≤120分钟。

临床怎么用

  • 应将FMC-to-device时间作为STEMI救治质量的核心监测指标。
  • 低绩效医院需针对急诊停留、导管室到PCI时间及转运延迟等环节改进流程。

局限性

  • 回顾性横断面设计,仅能提示关联而非因果。
  • 数据来自质量改进注册研究,可能存在选择偏倚和未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Percutaneous coronary intervention (PCI) is the criterion standard for acute ST-elevation myocardial infarction (STEMI). Achieving target first medical contact (FMC)-to-device time is a quality metric in STEMI care. OBJECTIVES: To describe site-level variability in achieving target FMC-to-device time (≤90 minutes for primary presentations to PCI-capable hospitals and ≤120 minutes for transfers), compare treatment times according to hospital performance, location, and primary PCI volume, and assess whether these aspects are associated with clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cross-sectional study from the American Heart Association Get With the Guidelines-Coronary Artery Disease registry from 2020 to 2022. Patients were recruited from a multicenter quality-improvement registry across 503 US hospitals. Patients with STEMI or STEMI equivalent who underwent primary PCI were included in this analysis. EXPOSURES: FMC-to-device time. MAIN OUTCOMES AND MEASURES: Hospital performance was determined by the proportion of patients meeting target FMC-to-device time at each site. Treatment times and outcomes were compared by hospital performance, location, and primary PCI volume. RESULTS: A total of 73 826 patients were analyzed (median [IQR] age, 62 [54-71] years; 53 474 male [72.4%]). Of 60 109 patients who presented directly to PCI-capable hospitals (primary presentations), 35 783 (59.5%) achieved an FMC-to-device time of 90 minutes or less, whereas 6900 (50.3%) of 13 717 transfers had an FMC-to-device time of 120 minutes or less. There was substantial institutional variability in achieving target FMC-to-device time for both primary presentations (median [IQR], 60.8% [51.2%-68.8%]) and transfers (median [IQR], 50.0% [32.5%-66.9%]). High-performing centers met all target treatment times more frequently. Low-performing sites experienced prolonged emergency department stays, catheterization laboratory arrival-to-PCI times, and transfer delays, varying by mode of presentation. Compared with urban centers, presentation to rural hospitals did not affect the odds of meeting target FMC-to-device time for primary presentations (adjusted odds ratio [aOR], 1.20; 95% CI, 0.96-1.50) or transfers (aOR, 0.86; 95% CI, 0.50-1.47). Failure to achieve target FMC-to-device time was associated with increased in-hospital mortality risk for primary presentations (aOR, 2.21; 95% CI, 2.02-2.42) and transfers (aOR, 2.44; 95% CI, 1.90-3.12). Low hospital performance was associated with increased mortality risk compared with high performance in primary presentations (aOR, 1.16; 95% CI, 1.00-1.34). Outcomes were similar between rural vs urban and low vs high primary PCI volume centers. CONCLUSIONS AND RELEVANCE: In this large cross-sectional study of patients with STEMI, there was substantial hospital-level variability in achieving target treatment times. Patients in whom target FMC-to-device time was not met and those presenting to low-performing hospitals had worse outcomes.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Sammour YM, Khan SU, Hong H, et al. Institutional Variability in Processes of Care and Outcomes Among Patients With STEMI in the US. JAMA Cardiol. 2025. PMID: 40498491. doi:10.1001/jamacardio.2025.1411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。